Top Markets
#1 MowCat MowCat +366.96%
#2 龙虾 (Lobster) 龙虾 (Lobster) +66.88%
#3 SODAX SODAX +49.11%
#4 Cortex Cortex +33.10%
#5 MANTRA MANTRA +24.62%
#6 DexNet DexNet +23.19%
#7 OpenEden OpenEden +18.34%
#8 Akedo Akedo +17.29%
#9 BNB Attestation Service BNB Attestation Service +16.69%
#10 Pons Pons +15.31%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
China National Accord Medicines Corporation Ltd. China National Accord Medicines Corporation Ltd.

China National Accord Medicines Corporation Ltd.

000028
Rank in Stocks #7536
China National Accord Medicines Corporation Ltd. primarily focuses on the... China National Accord Medicines Corporation Ltd. primarily focuses on the wholesale and retail distribution of a wide array of pharmaceutical and medical products. The company's extensive product offerings include traditional Chinese remedies, advanced biochemical and biological medicines, diagnostic agents, and antibiotics. Additionally, it supplies various chemical preparations, food items, industrial chemicals, and a diverse range of other general commodities. Beyond its core sales activities, the company is involved in selling medical apparatus and instruments. It offers comprehensive logistics services, encompassing freight transportation, warehousing, and cargo handling, alongside professional consulting. Further diversifying its operations, it markets glassware, cosmetics, and daily necessities, and provides goods agency services. The firm also participates in the import and export of technology, leases properties, and engages in the wholesale and retail of health-related products. As of December 31, 2021, China National Accord Medicines managed a significant network of 8,798 drugstores across 20 provinces, autonomous regions, and municipalities within China. This expansive retail footprint included 7,257 directly owned stores and 1,541 franchised locations. Established in 2004 and based in Shenzhen, China, the company operates as a subsidiary of Sinopharm Group Co., Ltd.
Share Price
$2.90
Market Cap
$1.55B
Change (1 day)
0.15%
Change (1 year)
-11.06%
Country
CN
Trade China National Accord Medicines Corporation Ltd. (000028)

Category

Healthcare
P/E ratio for China National Accord Medicines Corporation Ltd. (000028)
P/E ratio as of 2026 TTM: 0
According to China National Accord Medicines Corporation Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for China National Accord Medicines Corporation Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
McKesson Corporation McKesson Corporation
McKesson Corporation
MCK.US
 23.15 -
US
Cencora, Inc. Cencora, Inc.
Cencora, Inc.
COR.US
 - -
US
Cardinal Health, Inc. Cardinal Health, Inc.
Cardinal Health, Inc.
CAH.US
 32.35 -
US
AmerisourceBergen Corporation AmerisourceBergen Corporation
AmerisourceBergen Corporation
ABC.US
 - -
US
Sigma Healthcare Limited Sigma Healthcare Limited
Sigma Healthcare Limited
SIG.AX
 -338.64 -
AU
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.